U.S. Botulinum Toxin Market Size & Outlook, 2026-2033
Global Market
Related Markets
U.S. botulinum toxin market highlights
- The U.S. botulinum toxin market generated a revenue of USD 5,490.5 million in 2025 and is expected to reach USD 11,531.1 million by 2033.
- The U.S. market is expected to grow at a CAGR of 9.8% from 2026 to 2033.
- In terms of segment, type a was the largest revenue generating product in 2025.
- Type A is the most lucrative product segment registering the fastest growth during the forecast period.
Botulinum toxin market data book summary
| Market revenue in 2025 | USD 5,490.5 million |
| Market revenue in 2033 | USD 11,531.1 million |
| Growth rate | 9.8% (CAGR from 2026 to 2033) |
| Largest segment | Type a |
| Fastest growing segment | Type A |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Type B, Type A |
| Key market players worldwide | Ipsen SA, Merz Pharma, US WorldMeds, Galderma Group AG Registered Shares, Evolus Inc, Allergan, Metabiologics, Lanzhou Institute Of Biological Products |
Other key industry trends
- In terms of revenue, U.S. accounted for 41.7% of the global botulinum toxin market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. botulinum toxin market is projected to lead the regional market in terms of revenue in 2033.
- Canada is the fastest growing regional market in North America and is projected to reach USD 1,563.5 million by 2033.
The botulinum toxin market in the U.S. accounted for 79.5% of North America’s market. High disposable income and growing awareness about the availability of a variety of esthetic procedures are some of the factors responsible for market growth.
According to an article published by the American Society of Plastic Surgeons, around 7,347,900 noninvasive esthetic procedures were performed in the country in 2021, of which 2,520,000 were botulinum toxin fillers accounting for 47.1% of the total noninvasive treatments performed in the country.
This can be attributed to factors such as technological advancements, relatively higher disposable income, and availability of a number of esthetic procedures in the country. In addition, adoption among millennials tripled in the past 4 years in the U.S., accounting for over 1 million individuals undergoing esthetic procedures in 2018.
No credit card required*
Publish Date: Jun 30, 2026
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Botulinum Toxin Market Scope
Botulinum Toxin Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Allergan | View profile | 10001+ | Madison, Wisconsin, United States, North America | www.allergan.com |
| Galderma Group AG Registered Shares | View profile | - | Zählerweg 10, Zug, Switzerland, 6300 | www.galderma.com |
| Merz Pharma | View profile | 5001-10000 | Deutsch, Sachsen, Germany, Europe | www.merz.com |
| Ipsen SA | View profile | 5,325 | 65 Quai Georges Gorse, Billancourt Cedex, Boulogne, France, 92100 | www.ipsen.com |
| US WorldMeds | View profile | 51-100 | Louisville, Kentucky, United States, North America | www.usworldmeds.com |
| Evolus Inc | View profile | 279 | 520 Newport Center Drive, Suite 1200, Newport Beach, CA, United States, 92660 | www.evolus.com |
| Metabiologics | View profile | 11-50 | Madison, Wisconsin, United States, North America | www.metabiologics.com/ |
| Lanzhou Institute Of Biological Products | View profile | 11-50 | Lanzhou, Gansu, China, Asia | www.vacmic.com |
U.S. Botulinum Toxin Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Botulinum Toxin Market Outlook will help companies and investors design strategic landscapes.
Type A was the largest segment with a revenue share of 108.14% in 2025.
Horizon Databook has segmented the U.S. botulinum toxin market based on type b, type a covering the revenue growth of each sub-segment from 2021 to 2033.
The botulinum toxin market in the U.S. accounted for 79.5% of North America’s market. High disposable income and growing awareness about the availability of a variety of esthetic procedures are some of the factors responsible for market growth.
According to an article published by the American Society of Plastic Surgeons, around 7,347,900 noninvasive esthetic procedures were performed in the country in 2021, of which 2,520,000 were botulinum toxin fillers accounting for 47.1% of the total noninvasive treatments performed in the country.
This can be attributed to factors such as technological advancements, relatively higher disposable income, and availability of a number of esthetic procedures in the country. In addition, adoption among millennials tripled in the past 4 years in the U.S., accounting for over 1 million individuals undergoing esthetic procedures in 2018.
- U.S. Botulinum Toxin Market Product Outlook (Revenue, USD Million , 2021-2033)
- Type A
- Type B
- U.S. Botulinum Toxin Market Application Outlook (Revenue, USD Million , 2021-2033)
- Therapeutic
- Aesthetic
- U.S. Botulinum Toxin Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Hospitals
- Dermatology Clinics
- Spas and Cosmetic Centers
Reasons to subscribe to Botulinum Toxin Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Botulinum Toxin Market Outlook databook
- Our clientele includes a mix of Botulinum Toxin Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. Botulinum Toxin Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.S. Botulinum Toxin Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
U.S. Botulinum Toxin Market, 2021-2033 (US$M)
U.S. botulinum toxin market statistics, by product, 2021-2033 (US$M)
